Loading...

PBMC and IPSC

We offer specialized services for the isolation of Peripheral Blood Mononuclear Cells (PBMCs) and the development of patient-specific induced Pluripotent Stem Cells (iPSCs). These services support personalized medicine by enabling tailored disease modeling and therapeutic applications.

Products

Explore

Our PBMCs are isolated from human whole blood using standardized density gradient centrifugation techniques, ensuring optimal cell viability and purity.

Our goal is to support your most ambitious scientific goals with high-quality cellular tools designed to accelerate breakthroughs in precision medicine and immuno-oncology.

PBMCs serve as essential tools for researchers seeking to:
  • Explore immune responses, T-cell activation, and immune checkpoint modulation.
  • Evaluate immune system interactions with experimental therapeutics.
  • Utilize PBMCs in cytotoxicity, proliferation, cytokine release, and mixed lymphocyte reactions.

Our iPSCs are reprogrammed from PBMCs under GMP-compliant conditions, offering a renewable and versatile cell source for personalized and regenerative medicine.

iPSCs serve as essential tools for researchers and clinicians seeking to:
  • Study patient-specific disease mechanisms using iPSCs differentiated into relevant cell types.
  • Develop targeted treatments based on an individual’s unique genetic and cellular profile.
  • Generate antigen-presenting cells or immune-modulating populations for next-generation vaccine platforms.
Features:
  • High Viability and Functional Potency
  • Ethically Sourced and IEC-Approved Donors
  • Custom Reprogramming Services Available
Applications:
  • Drug discovery studies
  • Immunological studies
  • Disease biomarker studies
  • Cancer vaccine development
  • Neurological disorder treatment
  • Disease modelling and gene therapy